Solution for Endotoxin Detection in Fetal Bovine Serum
Solution for Endotoxin Detection in Fetal Bovine Serum
BETMATEndotoxin Detection Background and Core Significance
Fetal Bovine Serum (FBS), as the most widely used natural medium additive in cell culture, is rich in proteins, growth factors, hormones, vitamins, and other essential nutrients for cell growth. It plays an irreplaceable role in fields such as cell biology research, biopharmaceuticals, and cell therapy. However, FBS is highly susceptible to endotoxin contamination throughout the entire chain of processes including collection, processing, separation, storage, and transportation.
Endotoxin (Lipopolysaccharide, LPS), a component of the cell wall of Gram-negative bacteria, can cause severe harm to the cell culture system and downstream applications once it enters FBS:
1. Undermining the stability of cell culture: Endotoxin can activate signaling pathways such as Toll-like receptor 4 (TLR4) on the cell surface, inducing cells to secrete large amounts of inflammatory factors such as tumor necrosis factor-α (TNF-α) and interleukin-1 (IL-1). This interferes with the normal proliferation, differentiation, and metabolism of cells, leading to changes in cell morphology, growth arrest, and even cell apoptosis, directly resulting in the failure of cell culture experiments.
2. Affecting the accuracy of experimental results: For experiments relying on cell models, such as drug screening and vaccine development, the cellular stress response triggered by endotoxin can
mask or interfere with the real effects of experimental drugs, leading to false-positive or false-negative results and seriously affecting the reliability of research data. 3. Endangering the safety of biological products: In the field of biopharmaceuticals, FBS is often used in the production of biological products such as recombinant proteins and monoclonal antibodies. If the endotoxin content in the serum exceeds the standard, endotoxin will enter the final product during the production process. When the product is used clinically, it may cause severe pyrogenic reactions in patients, such as fever, chills, and shock, endangering the patients' lives. Therefore, in accordance with authoritative standards such as the pharmacopoeia, endotoxin detection of FBS is important in controlling serum quality, ensuring the success rate of cell culture, and guaranteeing the safety of biological products.
Detection Method |
Principle |
Advantages |
Disadvantages |
Applicable Scenarios |
Gel-Clot Method |
Endotoxin activates the serine protease zymogen pathway triggered by Factor C in LAL, catalyzing the conversion of coagulogen into a gel. |
Simple operation; no expensive endotoxin detection equipment required. |
Only qualitative or semi-quantitative detection is possible, and accurate quantification cannot be achieved. Long detection time (60 minutes). |
Qualitative screening and preliminary semi-quantitative detection of endotoxin in bovine serum. |
Kinetic Turbidimetric Method |
Monitors the change in turbidity during the reaction between LAL and endotoxin, and calculates the concentration based on the reaction time. |
Accurate quantification; relatively fast detection speed (30-120 minutes); |
Requires the use of endotoxin detection instruments. |
Accurate quantitative detection of endotoxin in bovine serum. |
Kinetic Chromogenic Method |
Chromogenic groups are released during the reaction, and the concentration is calculated based on the change in absorbance. |
High sensitivity; wide linear range; strong anti-interference ability. |
High cost of instruments and reagents. |
Scenarios requiring high sensitivity (e.g., serum for cell therapy). |
Suggestions for method selection: For routine quality control of FBS, a combined of "preliminary screening by Gel-Clot Method + quantification by Kinetic Turbidimetric Method or Kinetic Chromogenic Method" can be adopted. For scenarios with high requirements on endotoxin level, such as cell therapy and biopharmaceuticals, the Kinetic Chromogenic Method is recommended to ensure detection sensitivity and accuracy.
Standard Endotoxin Tesing Process (Taking "Preliminary Screening by Gel-Clot Method + Quantification by Kinetic Turbidimetric Method" as an Example)
3.1 Sample Pretreatment
FBS has a complex composition (containing proteins, lipids, etc.), and direct detection is likely to interfere with the LAL reaction, so pretreatment is required:
1. Sample Thawing: Thaw the frozen FBS, avoiding repeated freezing and thawing. After thawing, mix gently to avoid violent shaking which may generate bubbles.
2. Dilution Treatment: Dilute the serum in gradients (usually 10-100 times) using LAL Reagent Water. The dilution factor should be determined based on the expected endotoxin level of the serum and the sensitivity of the LAL reagent to ensure that the concentration of the diluted sample falls within the linear range of detection and to reduce the interference of bovine serum on endotoxin detection.
3. Centrifugal Clarification: If the diluted sample is still turbid, centrifuge it at 4°C and 3000 rpm for 10-15 minutes, and take the supernatant as the sample to be tested.
3.2 Preparation of Reagents and Instrument
1. Reagent Selection and Verification:
- Limulus Amebocyte Lysate (LAL): According to the endotoxin limit of serum (usually requiring ≤0.06 EU/mL or ≤0.125 EU/mL), select a Gel-Clot Method LAL reagent with a sensitivity of 0.03 EU/mL and a Kinetic Turbidimetric Method LAL reagent with a matching sensitivity. Sensitivity verification is required for each batch of reagents before use.
- Endotoxin Standard: Control Standard Endotoxin (CSE) or Reference Standard Endotoxin (RSE), diluted into gradient concentrations with LAL Reagent Water, used for standard curve plotting and positive control.
- LAL Reagent Water: Endotoxin content less than 0.005 EU/mL.
2. Depyrogenation of Apparatus: All apparatus in contact with samples and reagents (pipettes, centrifuge tubes, reaction tubes, etc.) should be endotoxin free. Glass apparatus must be subjected to dry heat sterilization at 250°C for more than 30 minutes. Or disposable endotoxin-free apparatus should be used to avoid cross-contamination.
3.3 Operation of Preliminary Screening by Gel-Clot Method
1. Sample Loading: Add the following substances to pyrogen-free reaction tubes respectively:
- Test Samples: 0.1 mL diluted serum + 0.1 mL dissolved LAL reagent;
- Negative Controls: 0.1 mL LAL Reagent Water + 0.1 mL LAL reagent;
- Positive Controls: 0.1 mL 2λ standard endotoxin solution (λ = LAL reagent sensitivity) + 0.1 mL LAL reagent;
- For Sensitivity Verification: 0.1 mL standard endotoxin of different concentrations + 0.1 mL LAL reagent.
After sample loading, mix gently to avoid generating bubbles.
2. Incubation: Place the tubes in water bath at 37±1°C and incubate for 60±2 minutes, with no vibration allowed during this period.
3. Result Judgment: After incubation, gently take out the tubes and slowly invert them by 180°. If the gel is intact and does not flow, it is positive (endotoxin ≥ LAL reagent sensitivity); if the gel breaks or appears as a liquid, it is negative (endotoxin < LAL reagent sensitivity). The results are only valid when the negative control is negative, the positive control is positive, and the sensitivity verification is qualified.
3.4 Quantitative Detection by Kinetic Turbidimetric Method
For samples that are negative in the preliminary screening by the Gel-Clot Method or require accurate quantification, the Kinetic Turbidimetric Method is used for detection:
1. Construction of the Standard Curve: Dilute the standard endotoxin into more than 4 gradient concentrations (e.g., 0.01 EU/mL, 0.1 EU/mL, 1 EU/mL, 10 EU/mL), mix each with LAL reagent, add to a 96-well plate, place it in a kinetic incubating microplate reader, incubate at 37°C, and record the reaction time (time for turbidity to reach the threshold) corresponding to each concentration. Plot the standard curve: log10 Y= B(log10 X) + A, where Y= reaction time, X= endotoxin concentration, B = slope of the regression curve, A= the Y intercept. (R² must be ≥0.98).
2. Sample Detection: Mix the diluted serum sample to be tested with LAL reagent, add to the microplate well, perform detection under the same conditions, record the reaction time, according the standard curve to calculate the endotoxin concentration of the sample.
3. Result Correction: Calculate the endotoxin concentration in the undiluted serum according to the sample dilution factor.
features
1. Criteria for Result Judgment: The endotoxin limit is determined based on industry standards and application scenarios. Common judgment criteria are as follows:
- Research-grade FBS: Endotoxin ≤0.125 EU/mL;
- Biopharmaceutical-grade FBS: Endotoxin ≤0.06 EU/mL;
- Cell therapy-grade FBS: Endotoxin ≤0.03 EU/mL.
If the detection result is lower than the limit, it is judged as qualified;
if it is higher than the limit, it is unqualified, and further traceability
of the pollution source (such as the collection process, processing equipment, storage containers, etc.) is required.
2. Requirements for Report Content: The detection report should include the following core information:
- Sample Information: Serum batch number, source, production date, thawing time;
- Detection Information: Detection method, sensitivity of LAL reagent, instrument model, experimental date;
- Result Data: Original detection value, dilution factor, calculation result, limit standard;
- Quality Control Information: Negative control, positive control, correlation coefficient (R²) of the standard curve;
- Conclusion and Signature: Clearly state the judgment result, with signatures of the tester and reviewer.
Pollution Traceability and Quality Improvement Suggestions
If the endotoxin detection of FBS is unqualified, it is necessary to trace the pollution source throughout the entire production process and take improvement measures:
1. Source Control: Select qulified suppliers, require them to provide cattle health certificates and records of aseptic control during the collection process, and avoid purchasing fetal bovine raw materials from areas with high incidence of epidemics or pollution.
2. Processing stage: Optimize the serum separation and filtration processes (such as using 0.1 μm ultrafiltration membranes for filtration), and regularly perform dry heat sterilization or chemical disinfection on processing equipment (such as centrifuges, stirring tanks).
3. Storage and Transportation: Use sterile and pyrogen-free glass bottles or special plastic bags for packaging, control the storage temperature below -20°C, and use cold chain transportation during transportation to avoid container damage or microbial growth caused by temperature fluctuations.
4. Laboratory Management for bacterial endotoxin test: Establish a mandatory detection system for serum before storage, resolutely reject unqualified batches, and regularly monitor the endotoxin contamination of laboratory detection apparatus and the environment.